Cowen And Company, LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $115,500 - $556,950	-15,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $238,140 - $334,350	-9,000 Reduced 37.5%	15,000 $30,000
Q2 2021 Aug 13, 2021	SELL	$32.73 - $47.95 $196,379 - $287,700	-6,000 Reduced 20.0%	24,000 $13,000
Q1 2021 May 04, 2021	BUY	$40.39 - $56.73 $181,755 - $255,285	4,500 Added 17.65%	30,000 $47,000
Q4 2020 Feb 08, 2021	BUY	$51.77 - $66.18 $543,585 - $694,890	10,500 Added 70.0%	25,500 $191,000
Q3 2020 Nov 03, 2020	BUY	$43.8 - $58.16 $657,000 - $872,400	15,000 New	15,000 $101,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.